Literature DB >> 12149376

Hepatitis D virus genotypes in intravenous drug users in taiwan: decreasing prevalence and lack of correlation with hepatitis B virus genotypes.

Jia-Horng Kao1, Pei-Jer Chen, Ming-Yang Lai, Ding-Shinn Chen.   

Abstract

Of 368 hepatitis B virus (HBV)-infected intravenous drug users, 144 (39%) were positive for antibody to hepatitis D virus (anti-HDV). Anti-HDV-positive HBV carriers had a lower rate of positivity for HBV DNA than did anti-HDV-negative carriers (52 versus 73%, respectively). From 1986 to 1997, the average rate of decrease in the prevalence of HDV infection in this population was 4.7%/year.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12149376      PMCID： PMC120675          DOI： 10.1128/JCM.40.8.3047-3049.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  33 in total

1.  Mixed genotypes infection with hepatitis D virus.

Authors:  J C Wu; I A Huang; Y H Huang; J Y Chen; I J Sheen
Journal:  J Med Virol       Date:  1999-01       Impact factor: 2.327

2.  Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus--large-scale analysis using a new genotyping method.

Authors:  M Lindh; A S Andersson; A Gusdal
Journal:  J Infect Dis       Date:  1997-06       Impact factor: 5.226

3.  Phylogenetic analysis of hepatitis D viruses indicating a new genotype I subgroup among African isolates.

Authors:  Y Y Zhang; E Tsega; B G Hansson
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

4.  Hepatitis B virus (HBV)/hepatitis D virus (HDV) coinfection in outbreaks of acute hepatitis in the Peruvian Amazon basin: the roles of HDV genotype III and HBV genotype F.

Authors:  J L Casey; G A Niro; R E Engle; A Vega; H Gomez; M McCarthy; D M Watts; K C Hyams; J L Gerin
Journal:  J Infect Dis       Date:  1996-11       Impact factor: 5.226

Review 5.  The molecular biology of hepatitis delta virus.

Authors:  M M Lai
Journal:  Annu Rev Biochem       Date:  1995       Impact factor: 23.643

6.  Geographic distribution and genetic variability of hepatitis delta virus genotype I.

Authors:  A O Shakil; S Hadziyannis; J H Hoofnagle; A M Di Bisceglie; J L Gerin; J L Casey
Journal:  Virology       Date:  1997-07-21       Impact factor: 3.616

7.  Decreasing hepatitis D virus infection in Taiwan: an analysis of contributory factors.

Authors:  T I Huo; J C Wu; R Y Lin; W Y Sheng; F Y Chang; S D Lee
Journal:  J Gastroenterol Hepatol       Date:  1997-11       Impact factor: 4.029

8.  Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience.

Authors:  D S Chen; G C Kuo; J L Sung; M Y Lai; J C Sheu; P J Chen; P M Yang; H M Hsu; M H Chang; C J Chen
Journal:  J Infect Dis       Date:  1990-10       Impact factor: 5.226

Review 9.  Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S-gene.

Authors:  L O Magnius; H Norder
Journal:  Intervirology       Date:  1995       Impact factor: 1.763

10.  Factors associated with viremia and elevated transaminase levels in asymptomatic hepatitis D virus-infected risk groups.

Authors:  J C Wu; C S Li; C L Chen; W Y Sheng; S D Lee; K J Lo
Journal:  J Med Virol       Date:  1994-01       Impact factor: 2.327
View more
  9 in total

1.  Current prevalence of hepatitis delta virus (HDV) infection and the range of HDV genotypes in Lebanon.

Authors:  S Ramia; M El-Zaatari; A I Sharara; F Ramlawi; B Farhat
Journal:  Epidemiol Infect       Date:  2006-12-19       Impact factor: 2.451

2.  Molecular epidemiology of hepatitis D virus infection among injecting drug users with and without human immunodeficiency virus infection in Taiwan.

Authors:  Sui-Yuan Chang; Chia-Ling Yang; Wei-Shin Ko; Wen-Chun Liu; Chi-Ying Lin; Cheng-Hsin Wu; Yi-Chin Su; Shu-Fang Chang; Mao-Yuan Chen; Wang-Huei Sheng; Chien-Ching Hung; Shan-Chwen Chang
Journal:  J Clin Microbiol       Date:  2010-12-29       Impact factor: 5.948

3.  Hepatitis D virus infection, replication and cross-talk with the hepatitis B virus.

Authors:  Chi-Ruei Huang; Szecheng John Lo
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

Review 4.  Hepatitis D: Scenario in the Asia-Pacific region.

Authors:  Zaigham Abbas; Wasim Jafri; Sajjad Raza
Journal:  World J Gastroenterol       Date:  2010-02-07       Impact factor: 5.742

5.  High prevalence of hepatitis delta virus among patients with chronic hepatitis B virus infection and HIV-1 in an intermediate hepatitis B virus endemic region.

Authors:  Shanmugam Saravanan; Vidya Madhavan; Vijayakumar Velu; Kailapuri G Murugavel; Greer Waldrop; Sunil S Solomon; Pachamuthu Balakrishnan; Nagalingeswaran Kumarasamy; Davey M Smith; Kenneth H Mayer; Suniti Solomon; Sadras P Thyagarajan
Journal:  J Int Assoc Provid AIDS Care       Date:  2013-05-30

6.  The impact of vaccination and antiviral therapy on hepatitis B and hepatitis D epidemiology.

Authors:  Ashish Goyal; John M Murray
Journal:  PLoS One       Date:  2014-10-14       Impact factor: 3.240

7.  Prevalences and associated risk factors of HCV/HIV co-infection and HCV mono-infection among injecting drug users in a methadone maintenance treatment program in Taipei, Taiwan.

Authors:  Yung-Feng Yen; Muh-Yong Yen; Lien-Wen Su; Lan-Huei Li; Peing Chuang; Xiao-Ru Jiang; Chung-Yeh Deng
Journal:  BMC Public Health       Date:  2012-12-11       Impact factor: 3.295

8.  How hepatitis D virus can hinder the control of hepatitis B virus.

Authors:  Maria Xiridou; Barbara Borkent-Raven; Joost Hulshof; Jacco Wallinga
Journal:  PLoS One       Date:  2009-04-21       Impact factor: 3.240

9.  Performance of commercially available anti-HDV enzyme-linked immunosorbent assays in Taiwan.

Authors:  Guan-Yu Lin; Yi-Le Wu; Cheng-Si Wang; Chia-Yun Ko; Chien-Hung Chen; Pei-Jer Chen; Po-Hsin Peng; Chao-Wei Hsu
Journal:  Virol J       Date:  2020-06-16       Impact factor: 4.099
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.